This is achieved in an all-synthetic robust assay which eliminates the need for centrifuges, pipettes, medically trained personnel, refrigeration or specialist equipment. Our novel ‘electronic signal amplification’ process can be applied to all molecular detection currently requiring ‘biological amplification’ e.g. PCR, LAMP & Sequencing, including high through put laboratory systems. Importantly, our product focus is on bringing to market a single use hand held device that we can prime with our proprietary PNA beads to target any virus or pathogen; and within the device we can multi-plex with multiple specific PNA beads, to detect up to twenty-four different viruses or pathogens in one single test.
Immediate encrypted digital wireless upload of results will enable realtime epidemiological tracking. In the emerging era of “test-and-treat” and “test-at-home” policies, UbiHealth will facilitate decentralisation of healthcare and enable many new benefits, at point-of-care and in home telemedicine.